SPC230
Kladribín
Status:
AfskrifuðApplication date:
16.7.2018Application published:
15.8.2018Grant published:
15.7.2020
Max expiry date:
19.12.2030Medicine name:
MavencladMedicine for children:
No
Timeline
Today
16.7.2018Application
15.8.2018Publication
15.7.2020Registration
19.12.2030Expires
Marketing license
IS authorization number:
EU/1/17/1212/001-006Date:
13.9.2017
Foreign authorization number:
EU/1/17/1212Date:
22.8.2017
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, Coinsins, Vaud CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2805723